Imunon, Inc. Line of Credit Facility, Periodic Payment, Interest
Imunon, Inc. (IMNN) reported Line of Credit Facility, Periodic Payment, Interest of $384.61 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityPeriodicPaymentInterest · last filed 2013-11-12
- Imunon, Inc. line of credit facility, periodic payment, interest for the quarter ending 2013-09-30 was $141.23K, a 3.85% decline year-over-year.
- Imunon, Inc. line of credit facility, periodic payment, interest for the quarter ending 2013-06-30 was $96.50K.
- Imunon, Inc. line of credit facility, periodic payment, interest for the quarter ending 2013-03-31 was $146.88K.
- Imunon, Inc. line of credit facility, periodic payment, interest for the quarter ending 2012-09-30 was $146.88K.
| Period end | Line of Credit Facility, Periodic Payment, Interest 3 month | Line of Credit Facility, Periodic Payment, Interest 6 month | Line of Credit Facility, Periodic Payment, Interest 9 month |
|---|---|---|---|
| 2013-09-30 | $141.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $237.73K derived: sum of 2 quarters · filed 2013-11-12 | $384.61K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $96.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $243.38K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $146.88K 10-Q · filed 2013-05-09 | ||
| 2012-09-30 | $146.88K 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |